John Jagerson and Wade Hansen
John Jagerson and Wade Hansen (RSS)
Editors, SlingShot Trader

Read complete bio
Recent Articles

Trade of the Day: Qihoo 360 Technology (QIHU)

Apr. 22, 2015, 9:35 am EDT – We picked Qihoo 360 because its technical picture suggests a downturn. More 

Wall Street Reconsidering Energy Stocks

Apr. 16, 2015, 12:01 pm EDT – If the market is able to continue its bullish bounce, it may be time to start looking at energy stocks that have swung too far into negative territory as potential bullish candidates. More 

Trade of the Day: Harley Davidson (HOG)

Apr. 16, 2015, 9:12 am EDT – Harley Davidson is in a downward-trending channel. More 

Here’s How Financials Relate to Interest Rates

Apr. 9, 2015, 6:00 am EDT – We aren’t bearish on financials, but we are seeing signs that uncertainty is rising, which will probably keep a lid on further gains within the sector. More 

Trade of the Day: HollyFrontier Corp. (HFC)

Apr. 8, 2015, 8:58 am EDT – We like a bearish position on HollyFrontier because the company is relatively weak fundamentally and the stock recently broke support. More 

What Is the ‘New Normal’ of Interest Rate Policy?

Apr. 3, 2015, 6:00 am EDT – We expect slower -- or non-existent -- rate hikes to benefit income-payers, small-caps and retail firms directly or indirectly through 2015. More 

Best Stocks for 2015 – Noble Corp Still Poised for Upside

Apr. 2, 2015, 10:52 am EDT – Noble Corp has had a difficult start to 2015, but the resurgence in oil prices is still on the horizon, and NE stock stands to benefit nicely. More 

Trade of the Day: MBIA Inc. (MBI)

Apr. 1, 2015, 9:27 am EDT – MBI is in a particularly sensitive position because of losses related to bonds defaults. More 

Trade of the Day: Nordstrom (JWN)

Mar. 26, 2015, 10:19 am EDT – Nordstrom beat Wall Street revenue estimates by $30 million and saw same-store sales growth of 4.7% in the fourth quarter. More 

Is Biotech too “Frothy”?

Mar. 25, 2015, 11:45 am EDT – We can look for common issues that have appeared in the past before significant corrections, and from that perspective, biotechnology looks overheated. More